Immunic
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $114 |
Gross Profit | -43 | -43 | -35 | |
EBITDA | -25,579 | -27,040 | -26,782 | -25,140 |
EBIT | -25,579 | -27,083 | -26,825 | -25,175 |
Net Income | -25,579 | -26,820 | -25,473 | -25,175 |
Net Change In Cash | 0 | 0 | 0 | 114 |
Free Cash Flow | -20,207 | -24,645 | -21,823 | -22,966 |
Cash | 35,132 | 55,310 | 14,304 | 35,668 |
Basic Shares | 193,897 | 132,175 | 101,344 | 90,150 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -134 | -111 | -77 | -85 |
EBITDA | -97,918 | -99,112 | -86,441 | -91,580 |
EBIT | -98,052 | -99,223 | -86,518 | -91,665 |
Net Income | -100,507 | -93,612 | -120,407 | -92,794 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 20,875 | -40,459 | ||
Free Cash Flow | -85,030 | -71,162 | -65,256 | -83,300 |
Cash | 35,668 | 46,674 | 106,745 | 86,863 |
Basic Shares | 100,174 | 44,320 | 31,819 | 23,652 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.13 |
2025-06-30 | -$0.20 |
2025-03-31 | -$0.25 |
